findmyKOL

Gary Balady, MD

Basic profile

Boston University

ORCIDNPI
RegionBoston, MA · NortheastSpecialtyCardiovascular DiseaseFocusCardiology
Last active 2022findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2018Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Gary Balady is a Cardiology physician affiliated with Boston University. OpenAlex indexes 204 publications with 34,089 citations (h-index 64). By OpenAlex citation count, this profile ranks in the top 5% of Cardiovascular Disease profiles in the findmyKOL directory.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
204publications

Distinct works indexed by OpenAlex, matched via ORCID.

34,089citations

Total citations across indexed works.

64h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

732 Harrison Avenue, Fl 3
Preston Bldg
Boston, MA 021182309

Telephone

617-638-7490

Provider last certified this registry record 15 May 2026.

View the NPPES registry record

Industry payments

1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    90.6%
    Statin23.5%
    Rosuvastatin Calcium58%Atorvastatin Calcium42%
    Part D94 patients
    Beta blocker14.4%
    Metoprolol Succinate97%Labetalol Hcl3%
    Part D<11 patients

    + 11 more classes in this area

  • Blood & clotting

    7.4%
    Factor Xa inhibitor6.4%
    Eliquis69%Xarelto31%
    Part D27 patients
    P2Y12 inhibitor1%
    Clopidogrel100%
    Part D<11 patients
  • Metabolism & gastrointestinal

    2%
    SGLT2 inhibitor1.3%
    Jardiance100%
    Part D<11 patients
    Potassium supplement0.7%
    Potassium Chloride100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”